AEGiS-Reuters: Agouron says JT is partner in HIV research

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Agouron says JT is partner in HIV research

Reuters NewMedia, Inc. - Monday December 23 6:59 PM EST

TOKYO, Dec 24 (Reuter) - Agouron Pharmaceuticals Inc and Japan Tobacco Inc 2914.T said that the anti-HIV drug for which Agouron had submitted a new drug application to the U.S. Food and Drug Administration was being jointly developed by the two companies.

U.S. pharmaceutical maker Agouron said on Monday that it had submitted a new drug application covering its HIV drug VIRACEPT to the FDA.

"VIRACEPT is being developed by Agouron in collaboration with the pharmaceutical division of Japan Tobacco Inc," the U.S. company said in a statement.

VIRACEPT is a synthetic chemical compound designed to inhibit the HIV protease-an enzyme that plays an essential role in the replication of HIV, the U.S. firm said.
961223
RE9612A2

Copyright © 1996 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .